Pharmacogenetics and future drug development and delivery
- 1 April 2000
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 355 (9212), 1358-1361
- https://doi.org/10.1016/s0140-6736(00)02126-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The essence of SNPsGene, 1999
- Further Evidence Linking Late-Onset Alzheimer Disease With Chromosome 12Published by American Medical Association (AMA) ,1999
- A 4-Mb High-Density Single Nucleotide Polymorphism-Based Map around Human APOEGenomics, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1998
- Familial Multiple-System Tauopathy with Presenile Dementia Is Localized to Chromosome 17American Journal of Human Genetics, 1997
- Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmaticsThe Lancet, 1997
- APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASEAnnual Review of Medicine, 1996
- Molecular genetics of diabetes mellitusBailliere's Clinical Endocrinology and Metabolism, 1995